Showing results (1671-1680 of 66,563) with videos related to
Sort By:
Pageof 6,657
The Journal of Pharmacy and Pharmacology|November 1, 1993
Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in ratsM Nadai, T Hasegawa, K Kato, et al.Plastic and Reconstructive Surgery. Global Open|October 25, 2017
Spontaneous Regression of Lymphangiomas in a Single Center Over 34 YearsMotoi Kato, Shoji Watanabe, Reiko Kato, et al.Hinyokika Kiyo. Acta Urologica Japonica|February 23, 2018
[Clinical Study of 2014 ISUP New Grade Group Classification for Prostate Cancer Patients Treated by Androgen Deprivation Therapy]Masahiro Uno, Makoto Kawase, Daiki Kato, et al.FEBS Letters|October 10, 2006
Depletion of Jab1 inhibits proliferation of pancreatic cancer cell linesAkihisa Fukumoto, Kiichiro Tomoda, Noriko Yoneda-Kato, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
Uptake of 18F-FDG in acute aortic dissection: a determinant of unfavorable outcomeKimihiko Kato, Akiko Nishio, Noriyuki Kato, et al.Molecular and Cellular Endocrinology|June 16, 2009
Dimeric PROP1 binding to diverse palindromic TAAT sequences promotes its transcriptional activityMichie Nakayama, Takako Kato, Takao Susa, et al.Digestive Diseases and Sciences|December 23, 2008
Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanismNaho Kato, Yuji Mashita, Shinichi Kato, et al.Springerplus|September 7, 2013
Use of in-vitro experimental results to model in-situ experiments: bio-denitrification under geological disposal conditionsKaoru Masuda, Hiroshi Murakami, Yoshitaka Kurimoto, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 9, 2013
Clinical backgrounds and the time course of sleep-disordered breathing in patients after myocardial infarctionHiroko Hayashi, Nagaharu Fukuma, Kazuyo Kato, et al.Japanese Journal of Clinical Oncology|April 2, 2014
Efficacy of everolimus in patients with advanced renal cell carcinoma refractory or intolerant to VEGFR-TKIs and safety compared with prior VEGFR-TKI treatmentRenpei Kato, Wataru Obara, Tomohiko Matsuura, et al.Pageof 6,657